GLP-1 receptor agonist (RA) medications are highly effective for managing weight and blood sugar, but they can also disrupt digestive healthleading to discomfort, irregularity, and microbial imbalance
Seeking professional medical advice from a qualified healthcare provider, prior to commencing treatment is strongly recommended when looking at compounds for semaglutide or other medications
Monitor your results closely
Australias Therapeutic Goods Administration (TGA) has approved semaglutide, dulaglutide and liraglutide for managing type 2 diabetes in adults, while tirzepatide is TGA-approved for the management of both type 2 diabetes and chronic weight management
No Hidden Fees Qualified applicants may be eligible for interest-free financing
References Richie JP Jr, Leutzinger Y, Parthasarathy S, Malloy V, Orentreich N, Zimmerman JA